Fringe modifies the ligand-selectivity of Notch in ways that are crucial for a number of Notch's developmental functions. Recent results have confirmed the suspicion that Fringe is a glycosyltransferase that works in the Golgi complex by modifying Notch's glycosylation state.
The Drosophila genome has one copy each of the genes for Notch and its ligands Delta and Serrate. Orthologs of these genes are found in many species, where they have been found to play a variety of developmental roles; mammals, for example, have four Notch-like and multiple ligand-like genes (reviewed in [5] [6] [7] ). The mature form of Notch is made by joining an extracellular and a transmembrane-intracellular fragment generated from the fulllength protein ( Figure 1 ). The extracellular portion of most Notch family members has 36 EGF-like repeats and three Lin-12-Notch repeats (LNRs). The transmembrane-intracellular portion has other conserved motifs required for signal transduction and modulation, including binding sites for the CBF1/Suppressor of Hairless/Lag-1 (CSL) transcription factor. Upon activation, the transmembrane-intracellular portion of Notch is cleaved and translocates, along with CSL, into the nucleus, where it activates transcription of CSL target genes.
The Delta-like and Serrate/Jagged-like Notch ligands are also transmembrane proteins, whose extracellular domains have one or more EGF-like repeats and a modified, EGFlike Delta-Serrate-Lag-2 (DSL) domain ( Figure 1 ). Serrate/Jagged-like ligands have more EGF-like repeats than Delta-like ligands and also have an extracellular cysteine-rich region.
Notch signaling is thought in most cases to be mediated by direct cell-cell contact, although the transmembrane ligands may be cleaved to generate diffusible forms [8] .
The EGF repeats in Notch are critical for ligand binding.
In Drosophila, Notch EGF repeats 11 and 12 are necessary and sufficient to bind Delta and Serrate [9] ; the other EGF repeats in Notch can modulate its activity, and mutations in these regions can alter ligand binding [10] . Mutations in the EGF repeats of the ligands can also reduce receptor binding and alter activity [10] , but the DSL region may be more critical for receptor-ligand interactions. The single EGF repeat on the Caenorhabditis elegans ligand Lag-2 is apparently dispensable for its function, while the DSL region is required [11] .
The Fringe family in development
Fringe was discovered in Drosophila, and named for its ability to regulate the formation of the 'fringe' of margin bristles found along the dorso-ventral compartment boundary in the developing wing imaginal disc (reviewed in [7, 12, 13] Notch signaling is more complex in vertebrates than in Drosophila, however, with multiple Notch and ligand genes expressed, and it has been difficult to confirm in vivo that Fringes always act by regulating Notch's sensitivity to particular ligands. In fact, vertebrate Fringes are sometimes co-expressed with Delta-like, instead of Serrate-like, molecules [12] . The best-analyzed systems are the apical ectodermal ridge in the limb bud of the chick, and the formation of somites [7, 13] . The chick apical ectodermal ridge is normally formed at a boundary of dorsal Radical Fringe expression, requires Notch activity, and is induced at boundaries of ectopic Radical Fringe expression. During somitogenesis, Lunatic Fringe is expressed in stripes in the presomitic mesoderm, and the defects observed in somite formation in Lunatic Fringedeficient knockout mice are very similar to those caused by Notch or Notch-ligand mutations.
The evidence
The first question is whether (Figure 1 ) -reduce binding [1] . Next, in what part of the cell does Fringe act? Fringe can be secreted [14] , which initially suggested that it acts extracellularly, perhaps by directly modifying the interactions between Notch and its ligands. On the other hand, work on the Drosophila wing suggested that Fringe's biological activity is limited to the cells expressing Fringe [14, 17] . Now it appears that Fringe acts intracellularly. Those forms of Notch that bind Fringe were found to co-localize with Fringe intracellularly, and Notch-Fringe binding was only observed when both proteins were expressed in the same cells [1] . Fringe has been found to be highly concentrated in the Golgi; moreover, an engineered form of Fringe targeted only for secretion lacked most biological activity in vivo [2] , whereas an engineered, non-secreted form of Fringe targeted specifically to the Golgi retained activity [3] . In vitro assays have also shown that Fringe acts intracellularly. Co-expression of Notch and Fringe increased the ability of Drosophila cells to bind Delta (although see [18] for a counterexample), but co-culture of separate Notch-expressing and Fringe-expressing cells did not [3] . In a separate study [16] , a mammalian reporter gene assay was used to measure Notch1 and Notch2 activity: Notch and Fringe had to be co-expressed in the same cells to potentiate signaling via Delta1 and reduce signaling via the Serrate-like Jagged1.
Is it simply the formation of an intracellular Notch-Fringe complex that regulates signaling, or does Fringe actually modify Notch in some fashion? In 1997 Yuan et al. [19] pointed out that Fringe slightly resembles a family of bacterial glycosyltransferases, the enzymes responsible for the addition and extension of sugar groups on glycoproteins. This might require intracellular activity, as much of this glycosylation takes place in the Golgi. Fringe has a DDD sequence motif; in glycosyltransferases, the DxD motif is required for catalytic activity. Mutating this site was found to block Fringe activity in vivo and in vitro [2] [3] [4] . Glycosyltransferases usually derive sugars from UDP, and Fringe was shown to bind UDP [2] . And Fringe increases the addition of a specific sugar to a specific substrate [3, 4] . The substrate must first bear a single 'acceptor' sugar group; different glycosyltransferases are specific for particular acceptors, to which they add specific 'donor' sugars. Drosophila Fringe, Manic Fringe and Lunatic Fringe were all specific for Fucose as an acceptor, and GlcNAc as a donor. This is particularly intriguing, as a recent study [20] has shown that the mammalian Notch1 protein is glycosylated by an O-linked fucose monosacccharide, which can be lengthened into a trisaccharide or tetrasaccharide; furthermore, the first sugar added to the fucose monosaccharide is GlcNAc (Figure 3 ). This type of glycosylation of proteins is rare: the initial O-fucose linkage is apparently limited to the serine or threonine within the CxxGGS/TC motif found within certain EGF-like repeats [20, 21] . This motif is found in many of the EGF-like repeats in almost all Notch family members (Figure 1 ) [20] . Fringe increased the incorporation of GlcNAc into fragments of Notch containing these specific EGF-like repeats [3, 4] , and Manic Fringe increased the length of the O-fucose-linked saccharides detected on truncated or full-length Notch1 [4] .
The link between glycosylation and Fringe activity was also assessed by using mutant cells defective in transferring fucose to proteins [4] . Co-culture of Notch1-expressing and Jagged1-expressing cells increased reporter gene activity, and this was reduced if the Notch1-expressing cells were co-transfected with Manic or Lunatic Fringe. In the mutant cells, however, Jagged1-dependent signaling was decreased, and Manic or Lunatic Fringe caused no further decrease in signaling [4] .
The model that emerges from all these observations is that Fringe binds to Notch in the Golgi and adds GlcNAc to the O-fucose saccharides found on specific EGF repeats. The relevance of forming a stable Notch-Fringe complex [1] is unclear -Fringe can glycosylate Notch fragments that lack both the EGF repeats 22-36 and LNR regions required for binding Fringe [3] . Curiously, while Abruptex mutations that alter specific EGF repeats were found to block Fringe binding to EGF repeats 22-36 in vitro, they potentiated the effects of Fringe misexpression in vivo [1, 22] . It is not yet known if these mutations affect glycosylation of Notch.
This glycosylation of Notch, and perhaps the subsequent addition of two additional sugars (Figure 3) , is postulated to increase Notch's sensitivity to Delta-like ligands and to decrease its sensitivity to Serrate/Jagged-like ligands. This change may result from altered ligand-receptor binding, at least in the case of Delta [3] ; this has not been confirmed for Serrate [3, 18] and more subtle regulation of activity is possible. Drosophila Notch EGF repeats 11 and 12 are thought to mediate ligand binding, but these do not contain the O-fucose linkage motif. Some of the Drosophila Abruptex gain-of-signaling mutations are missense substitutions near the O-fucose linkage sites (Figure 1) , so it is possible these affect Fringe-mediated glycosylation and Tetrasaccharide detected on Notch [20] ; Fringe catalyses the addition of the second sugar group [3, 4] .
Fringe
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Sia-α2 6-Gal-β1 4-GlcNAc-β1 3-Fuc-α1 O-Ser/Thr + allow, for instance, activation by Serrate-like ligands. However, none of the Abruptex mutations that have been sequenced alters the O-fucose linkage motifs themselves, and Ax E2 reduces Notch-Delta binding in vitro [10] .
Fringe and other substrates?
One issue raised by these studies is whether the Fringemediated glycosylation is limited to Notch. Many other proteins have the O-fucose linkage motif [20, 21] , including most Notch ligands (Figure 1) . C. elegans does not have any fringe-like genes, and the linkage motif is lacking from most EGF-like repeats in the C. elegans orthologs of Notch (Lin-12 and Glp-1) and its three ligands (Apx-1, Lag-1 and Arg-1); the only exceptions are one repeat each in Glp-1 and Arg-1. In fairness, however, the C. elegans molecules differ from their vertebrate and Drosophila cousins in many other respects, and these motifs could have been lost for other reasons.
Is there any evidence for direct Fringe-ligand interactions? The in vitro activity assays were unable to detect any effect on Notch signaling when Fringe was expressed in the ligand-expressing rather than the Notch-expressing cell [4, 16] . On the other hand, when excess Delta or Serrate was expressed within the neuronal cell in the developing sensory organs of Drosophila, it inhibited bristle development in the adjacent bristle precursor, converting it into a socket cell; this signaling was blocked when Fringe was co-expressed with either Delta or Serrate [23] .
Fringe and cell-autonomous interactions?
As endogenous Notch is also expressed in the neuronal precursor, however, there is another explanation for this last result. Co-expression of excess Notch along with excess ligand in the neuronal cell also reduced signaling to the bristle precursor [23] . This suggests that Notch can interact in 'cis' with the Delta or Serrate expressed on the same cell, sequestering ligands and blocking signaling to adjacent cells. Binding between Notch and Delta has in fact been detected on the membrane of a single cell [24] . Thus, Fringe could glycosylate the endogenous Notch expressed on the neuronal cell and increase its cis interaction with ligand. If this does occur, there is one crucial difference with respect to the effects of Fringe on 'trans' signaling: the modulation of cis binding does not appear to be ligand-specific.
Cis interactions between Notch its ligands have also been invoked to explain the fact that cells expressing high levels of ligands are reduced in their ability to receive Notch signals. In this model, ligands and Notch are thought to interact in the same cell in a way that prevents activation of Notch by ligands from adjacent cells. A recent study [22] suggests that the Abruptex gain-of-signaling Notch mutations are less sensitive to cis interactions with Delta or Serrate, explaining the reduced binding between Abruptex Notch proteins and ligands [10] . The glycosylation of Notch by Fringe might modulate this cis binding, and Abruptex mutants may alter this glycosylation. If Fringe does modify both cis and trans Notch-ligand interactions, and if the cis interaction is not ligand-specific, it could explain why in some circumstances Fringe does not appear to stimulate Delta activity [17, 23] .
More glycosylation?
An ever-increasing number of glycosyltransferases are being discovered (reviewed in [25] ), and many will undoubtedly be proven to play critical roles regulating developmental signaling. For instance, the Brainiac protein, which is also implicated in some types of Notch signaling in Drosophila, is quite similar to a growing family of β1,3-galactosyltransferases [19, 25, 26] . The tetrasaccharide regulated by Fringe does not appear to contain the linkages typically catalyzed by this family of proteins, so Brainiac may modify a different substrate.
The new work linking Fringe and glycosylation comes at a time of increased interest in the role of glycosylation and proteoglycans in developmental signaling. Recent genetic studies [27, 28] have linked components of these processes to very specific signaling pathways, such as those mediated by Hedgehog, Wingless/Wnt and BMP/Dpp. The regulated glycosylation of a receptor such as Notch can only increase this interest.
